With the approval, Furoscix becomes the first and only FDA-approved subcutaneous loop diuretic for the at-home treatment of congestion in heart failure.
The infusor enables subcutaneous administration at home by the patient or a caregiver. Once the pre-filled cartridge is inserted into the pre-programmed single-use on-body infusor for Furoscix and attached to the abdomen, the device is activated with the press of a button to deliver an 80mg dose over five hours.
